News | July 28, 2022
Novartis India Q1FY23 PAT jumps to Rs. 52.38 Cr
Novartis India has reported total income of Rs. 147.44 crores during the period ended June 30, 2022.
Novartis India has reported total income of Rs. 147.44 crores during the period ended June 30, 2022.
Dr. Lal Path Labs has reported total income of Rs. 511 crores during the period ended June 30, 2022
Aarti Drugs Limited has reported total income of Rs. 622.22 crores during the quarter ended June 30, 2022.
The company has reported total income of Rs. 186.97 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 94.30 crores during the period ended June 30, 2022.
GlaxoSmithKline Pharmaceuticals has reported total income of Rs. 772.71 crores during the period ended June 30, 2022
Suven Life Sciences has reported total income of Rs. 3.97 crores during the period ended June 30, 2022
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
Company raises the annual revenue guidance from mid-teens to high teens
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
Subscribe To Our Newsletter & Stay Updated
